Skip to main content
SpringerLink
Log in

The Mean Dissolution Time Depends on the Dose/Solubility Ratio

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To investigate the relationship between mean dissolution time (MDT) and dose/solubility ratio (q) using the diffusion layer model.

Methods. Using the classic Noyes-Whitney equation and considering a finite dose, we derived an expression for MDT as a function of q under various conditions. q was expressed as a dimensionless quantity by taking into account the volume of the dissolution medium. Our results were applied to in vitro and in vivo data taken from literature.

Results. We found that MDT depends on q when q > 1 and is infinite when q > 1 and that the classic expression of MDT = 1/k, where k is the dissolution rate constant, holds only in the special case of q = 1. For the case of perfect sink conditions, MDT was found to be proportional to dose. Using dissolution data from literature with q < 1, we found better estimates of MDT when dependency on dose/solubility ratio was considered than with the classic approach. Prediction of dissolution limited absorption was achieved for some of the in vivo drug examples examined.

Conclusion. The mean dissolution time of a drug depends on dose/solubility ratio, even when the model considered is the simplest possible. This fact plays an important role in drug absorption when absorption is dissolution limited.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. K. Yamaoka, T. Nakagawa, and T. Uno. Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm. 6:547-558 (1978).

    Google Scholar 

  2. D. Brockmeier. Mean time concept and component analysis in pharmacokinetics. Int. J. Clin. Pharmacol. Ther. 37:555-561 (1999).

    Google Scholar 

  3. D. Brockmeier, D. Voegele, and H.M von Hattinberg. In vitro-in vivo correlation, a time sampling problem. Arzneim. Forsch. Drug Res. 33:598-601 (1983).

    Google Scholar 

  4. P. Lansky and M. Weiss. Does the dose-solubility ratio affect the mean dissolution time of drugs? Pharm. Res. 16:1470-1476 (1999).

    Google Scholar 

  5. A. S. Noyes and W. R. Whitney. The rate of solution of solid substances in their own solutions. J. Amer. Chem. Soc. 19:930-934 (1897).

    Google Scholar 

  6. Y. Tanagawara, K. Yamaoka, T. Nakagawa, and T. Uno. New method for the evaluation of in vitro dissolution time and disintegration time. Chem. Pharm. Bul. 30:1088-1090 (1982).

    Google Scholar 

  7. R. K. Brazzell and S. A. Kaplan. Factors affecting the accuracy of estimated mean absorption times and mean dissolution times. J. Pharm. Sci. 72:713-715 (1983).

    Google Scholar 

  8. K. C. Khoo, M. Gibaldi, and R. K. Brazzell. Comparison of statistical moment parameters to Cmax and tmax for detecting differences in in vivo dissolution rates. J. Pharm. Sci. 74:1340-1342 (1985).

    Google Scholar 

  9. N. D. Eddington, P. Marroum, R. Uppoor, A. Hussain, and L. Augsburger. Development and internal validation of an in vitro-in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation. Pharm. Res. 15: 466-473 (1998)

    Google Scholar 

  10. N. D. Eddington, P. Marroum, R. Uppoor, A. Hussain, and L. Augsburger. Erratum. Pharm. Res. 15:1320(1998).

    Google Scholar 

  11. L. X. Yu and J. R. Crison. and G.L Amidon. Compartmental transit and dispersion model analysis for small intestinal transit flow in humans. Int. J. Pharm. 140:111-118 (1996).

    Google Scholar 

  12. L. X. Yu. An integrated model for determining causes of poor oral drug absorption. Pharm. Res. 16:1883-1887 (1999).

    Google Scholar 

  13. J. B. Dressman and D. Fleisher. Mixing-tank model for predicting dissolution rate control of oral absorption. J. Pharm. Sci. 75:109-116 (1986).

    Google Scholar 

  14. G. L. Amidon, H. Lennernas, V. P. Shah, and J. R. Crison. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:413-420 (1995).

    Google Scholar 

  15. L. X. Yu, G. L. Amidon, J. E. Polli, H. Zhao, M. U. Mehta, D. P. Conner, V. P. Shah, L. J. Lesko, M. L. Chen, V. H. Lee, and A. S. Hussain. Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm. Res. 19:921-925 (2002).

    Google Scholar 

  16. L. X. Yu, E. Lipka, and G. L. Amidon. Transport approaches to the biopharmaceutical design of oral drug delivery systems. Adv. Drug Deliv. Rev. 19:359-376 (1996).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Biopharmaceutics and Pharmacokinetics, School of Pharmacy, University of Athens, Athens, 15771, Greece

    Eleni Rinaki, Aristides Dokoumetzidis & Panos Macheras

Authors
  1. Eleni Rinaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aristides Dokoumetzidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Panos Macheras
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Panos Macheras.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rinaki, E., Dokoumetzidis, A. & Macheras, P. The Mean Dissolution Time Depends on the Dose/Solubility Ratio. Pharm Res 20, 406–408 (2003). https://doi.org/10.1023/A:1022652004114

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022652004114

Search

Navigation